Archive · 2 Jun 2025
Marksans Pharma Receives UK Approval for Diabetes Drug
A company called Marksans Pharma has a part of its business called Relonchem.
Relonchem got permission from the UK government to sell a medicine called Metformin Hydrochloride.
This medicine comes as a liquid that people with type 2 diabetes can drink.
This is good news because the company can now sell this medicine in the UK.
It is used to help control high blood sugar levels.
The company also got approval for other medicines, like ones for constipation and nerve pain.
People who invest in the company were happy and the price of the company's stock went up.
Marksans Pharma's subsidiary, Relonchem Ltd, received UKMHRA approval.
The approval is for Metformin Hydrochloride oral solution (500 mg/5ml).
The drug is used to treat type 2 diabetes.
Relonchem also received approvals for other medications.
Shares of Marksans Pharma gained after the announcement.
- Who
- Marksans Pharma subsidiary Relonchem Ltd
- What
- Received marketing authorization for Metformin Hydrochloride oral solution
- When
- May 2024
- Where
- UK
- Why
- To expand presence in the anti-diabetic therapeutic segment
- Company
- Marksans Pharma Ltd
- Subsidiary
- Relonchem Ltd
- Drug Name
- Metformin Hydrochloride
- Strength
- 500 mg/5 ml
- Application
- Type 2 diabetes treatment
- Regulatory Body
- UKMHRA
- Recent Approvals
- Sennosides tablets, Gabapentin Oral Solution